(2S)-5-amino-2-[[(2S,3R)-2-azaniumyl-3-hydroxybutanoyl]amino]-5-oxopentanoate | 96337-79-0

• 物质功能分类: 生物化工 - 生化试剂 - 氨基酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-5-amino-2-[[(2S,3R)-2-azaniumyl-3-hydroxybutanoyl]amino]-5-oxopentanoate
• CAS: 96337-79-0
• 化学式: C9H17N3O5
• 分子量: 247.25
• InChiKey: BWUHENPAEMNGQJ-ZDLURKLDSA-N

物化性质

• 熔点：
  >208°C (subl.)
• 溶解度：
  可微溶于水
• 物理描述：
  Solid

计算性质

• 辛醇/水分配系数(LogP)：
  -4.4
• 重原子数：
  17
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  160
• 氢给体数：
  4
• 氢受体数：
  5

安全信息

• WGK Germany：
  3
• 海关编码：
  2924199090

文献信息

• Compositions to improve tic disorders
  申请人：Ozeki Makoto

  公开号：US20060217321A1

  公开（公告）日：2006-09-28

  Tic disorders can be improved by administering theanine, an amino acid that crosses the blood-brain barrier, or a dipeptide consisting of theanine and a different amino acid. In addition, these compositions can be added to foods and drinks or pharmaceuticals.

  滴状障碍可以通过给予茶氨酸改善，这是一种可以穿过血脑屏障的氨基酸，或者是由茶氨酸和另一种氨基酸组成的二肽。此外，这些组合物可以添加到食品和饮料或药品中。
• Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method
  申请人：Tonouchi Naoto

  公开号：US20050037453A1

  公开（公告）日：2005-02-17

  The present invention provides a method for producing dipeptide using inexpensively acquirable starting materials by an industrially advantageous and simple pathway. Dipeptide is produced from L-amino acid ester and L-amino acid using a culture of microbes having the ability to produce a dipeptide from an L-amino acid ester and an L-amino acid, using microbial cells isolated from the culture, or a treated microbial cell product of the microbe.

  本发明提供了一种使用成本低廉的起始材料通过工业上有利且简单的途径生产二肽的方法。通过使用具有从L-氨基酸酯和L-氨基酸生产二肽的能力的微生物培养物，使用从培养物中分离出的微生物细胞或经处理的微生物细胞产物，从L-氨基酸酯和L-氨基酸生产二肽。
• Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method
  申请人：Ajinomoto Co., Inc.

  公开号：EP1911839A1

  公开（公告）日：2008-04-16

  The present invention provides a method for producing dipeptide using inexpensively acquirable starting materials by an industrially advantageous and simple pathway. Dipeptide is produced from L-amino acid ester and L-amino acid using a culture of microbes having the ability to produce a dipeptide from an L-amino acid ester and an L-amino acid, using microbial cells isolated from the culture, or a treated microbial cell product of the microbe.

  本发明提供了一种利用廉价的可获得的起始原料，通过工业上有利的简单途径生产二肽的方法。二肽是利用具有从 L-氨基酸酯和 L-氨基酸中生产二肽能力的微生物培养物，使用从培养物中分离的微生物细胞或经处理的微生物细胞产物，从 L-氨基酸酯和 L-氨基酸中生产出来的。
• Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
  申请人：DermBiont, Inc.

  公开号：US11040077B2

  公开（公告）日：2021-06-22

  Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.

  本文公开了使用源自人类的 Lividum Janthinobacterium 的组合物和方法。组合物可改善皮肤健康。方法可包括在宿主或宿主区域（如皮肤或粘膜）上施用源于人的生发的Lividum Janthinobacterium，以最大限度地减少一种或多种微生物的存在，最大限度地提高治疗效果，和/或改善健康状况。减少病原微生物的方法可包括向表面施用一种组合物，该组合物包括来源于人类的Janthinobacterium lividum和一种可接受的载体。组合物和方法可包括益生元，以最大限度地提高生长和/或代谢物。组合物和方法可包括来源于人的猪蓝细菌代谢物，如violacein、prodigiosin、吲哚-3-甲醛、兰特益生菌和/或其他后益生菌。
• PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE
  申请人：Ajinomoto Co., Inc.

  公开号：EP1411116B1

  公开（公告）日：2008-04-23